The University of Hong Kong at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

The University of Hong Kong takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on precision oncology, from multi-omic liquid biopsy signals to putting tumour-agnostic therapies into everyday practice. It also presents updated results for a personalised neoantigen vaccine combined with precision radiotherapy to critical lesions in advanced solid tumours.

OrganizationESMO 2026 Attendance
The University of Hong Kong
Hong Kong, Hong Kong SAR China
hku.hk
University & institute
Public research university in Hong Kong with a faculty of medicine.
Satellite
Fri Oct 23
10:27–10:39
The Role of Multi-Omic Signals for Next Generation Precision Oncology and
Gene Solutions - AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation
Biomarkers & precision oncology
Abstract
Sat Oct 24
08:35–08:40
Talk
Mon Oct 26
15:35–16:00
Implementing tumour-agnostic therapies in clinical practice
Tumour-agnostic oncology: From concept to clinical practice
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from The University of Hong Kong

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction